Gossamer Bio Inc.

7.60+0.0400+0.53%Vol 108.38K1Y Perf -44.35%
Jul 27th, 2021 13:06 DELAYED
BID7.59 ASK7.61
Open7.50 Previous Close7.56
Pre-Market- After-Market-
 - -%  - -
Target Price
21.00 
Analyst Rating
Strong Buy 1.00
Potential %
176.68 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-100/25 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-100/90 
Growth Ranking
★+     43.35
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/89 
Income Ranking
 —    -
Market Cap576.92M 
Earnings Rating
Buy
Price Range Ratio 52W %
6.97 
Earnings Date
10th Aug 2021

Today's Price Range

7.417.67

52W Range

7.0415.08

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-0.66%
1 Month
-7.92%
3 Months
-13.10%
6 Months
-23.71%
1 Year
-44.35%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
GOSS7.600.04000.53
AAPL146.19-2.8000-1.88
GOOG2 710.87-82.0200-2.94
MSFT284.58-4.4700-1.55
XOM57.62-0.8600-1.47
WFC45.110.10000.22
JNJ172.600.73000.42
FB365.94-6.5200-1.75
GE13.030.11000.85
JPM151.700.05000.03
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.80-0.782.50
Q04 2020-0.80-0.88-10.00
Q03 2020-0.86-0.806.98
Q02 2020-0.84-1.00-19.05
Q01 2020-0.80-0.87-8.75
Q04 2019-0.80-0.89-11.25
Q03 2019-0.71-0.80-12.68
Q02 2019-0.56-0.74-32.14
Earnings Per EndEstimateRevision %Trend
6/2021 QR-0.777.23Positive
9/2021 QR-0.756.25Positive
12/2021 FY-3.17-0.63Negative
12/2022 FY-3.13-18.11Negative
Next Report Date10th Aug 2021
Estimated EPS Next Report-0.77
Estimates Count2
EPS Growth Next 5 Years %4.20
Volume Overview
Volume108.38K
Shares Outstanding75.91M
Trades Count1.69K
Dollar Volume9.02M
Avg. Volume582.66K
Avg. Weekly Volume292.90K
Avg. Monthly Volume387.61K
Avg. Quarterly Volume507.48K

Gossamer Bio Inc. (NASDAQ: GOSS) stock closed at 7.56 per share at the end of the most recent trading day (a 1.61% change compared to the prior day closing price) with a volume of 314.27K shares and market capitalization of 576.92M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 171 people. Gossamer Bio Inc. CEO is Faheem Hasnain.

The one-year performance of Gossamer Bio Inc. stock is -44.35%, while year-to-date (YTD) performance is -21.82%. GOSS stock has a five-year performance of %. Its 52-week range is between 7.04 and 15.08, which gives GOSS stock a 52-week price range ratio of 6.97%

Gossamer Bio Inc. currently has a PE ratio of -2.20, a price-to-book (PB) ratio of 2.08, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -56.27%, a ROC of -57.91% and a ROE of -82.57%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Gossamer Bio Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.77 for the next earnings report. Gossamer Bio Inc.’s next earnings report date is 10th Aug 2021.

The consensus rating of Wall Street analysts for Gossamer Bio Inc. is Strong Buy (1), with a target price of $21, which is +176.68% compared to the current price. The earnings rating for Gossamer Bio Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Gossamer Bio Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Gossamer Bio Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.22, ATR14 : 0.34, CCI20 : -66.67, Chaikin Money Flow : 0.04, MACD : -0.26, Money Flow Index : 39.42, ROC : -5.03, RSI : 40.88, STOCH (14,3) : 45.61, STOCH RSI : 0.86, UO : 57.56, Williams %R : -54.39), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Gossamer Bio Inc. in the last 12-months were: Bryan Giraudo (Buy at a value of $30 036), Bryan Giraudo (Sold 5 490 shares of value $52 046 ), Christian Waage (Buy at a value of $23 818), Christian Waage (Sold 5 490 shares of value $52 051 ), Faheem Hasnain (Buy at a value of $2 999 986), Luisa Salter-Cid (Sold 5 491 shares of value $52 052 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include GB001 (DP2 Antagonist), GB002 (PDGF Receptor Kinase Inhibitor), GB004 (HIF-1a Stabilizer), and GB1275 (CD11b Modulator).

CEO: Faheem Hasnain

Telephone: +1 858 684-1300

Address: 3013 Science Park Road, San Diego 92121, CA, US

Number of employees: 171

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

20%80%

Bearish Bullish

61%39%

Bearish Bullish

50%50%

News

Stocktwits